| 3602 |
1392: Increase, Oxidative Stress |
1446: Decrease, Coupling of OXPHOS |
Aug 21, 2025 |
Aug 21, 2025 |
None
|
| 3616 |
1392: Increase, Oxidative Stress |
495: Repressed expression of steroidogenic enzymes |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3632 |
1392: Increase, Oxidative Stress |
1767: Increase, Protein oxidation |
Sep 8, 2025 |
Jun 23, 2026 |
8 AOPs
|
| 3690 |
1392: Increase, Oxidative Stress |
2363: Mito ROS dysfunction |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3791 |
1392: Increase, Oxidative Stress |
902: Inflammation, Liver |
Apr 27, 2026 |
Apr 27, 2026 |
2 AOPs
|
| 3808 |
1392: Increase, Oxidative Stress |
2431: Impact on sirtuins-related aging signaling pathway gene expression |
Jul 9, 2026 |
Jul 9, 2026 |
1 AOP
|
| 3811 |
1392: Increase, Oxidative Stress |
2436: Systemic inflammation |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 3819 |
1392: Increase, Oxidative Stress |
2440: Hepatic inflammation |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 3823 |
1392: Increase, Oxidative Stress |
2443: Hepatocyte injury |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 3829 |
1392: Increase, Oxidative Stress |
786: Increase, Cytotoxicity (hepatocytes) |
Jul 24, 2026 |
Jul 24, 2026 |
1 AOP
|
| 1362 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1281: Increased, DNA Damage-Repair |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1364 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1280: Activation, HIF-1 |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 3166 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
177: Increase, Mitochondrial dysfunction |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 3512 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1115: Increase, ROS |
Apr 3, 2025 |
Apr 3, 2025 |
1 AOP
|
| 2340 |
1865: Increase, OEC damage |
1862: Decrease, Photosystem II efficiency |
Apr 11, 2021 |
Apr 11, 2021 |
1 AOP
|
| 3552 |
2337: Increase, PLIN2 |
2333: Increase, Fat mass |
Jul 25, 2025 |
Jul 25, 2025 |
1 AOP
|
| 1241 |
1173: Increase, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1230 |
1170: Increase, Phenotypic enzyme activity |
716: Increase, cell proliferation (hepatocytes) |
Nov 29, 2016 |
Dec 31, 2020 |
1 AOP
|
| 1231 |
1170: Increase, Phenotypic enzyme activity |
1171: Increase, Clonal Expansion of Altered Hepatic Foci |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2409 |
1892: increase, placental insufficiency |
1893: increase, Preeclampsia |
May 31, 2021 |
May 31, 2021 |
1 AOP
|
| 254 |
220: Increase, Plasma vitellogenin concentrations |
252: Increase, Renal pathology due to VTG deposition |
Nov 29, 2016 |
Jun 24, 2024 |
2 AOPs
|
| 3259 |
220: Increase, Plasma vitellogenin concentrations |
364: Impaired development of, Reproductive organs |
Jul 3, 2024 |
Jul 3, 2024 |
1 AOP
|
| 1474 |
1375: Increase, platelet aggregation |
1367: Inhibit, gastric ulcer formation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 2555 |
1965: Increase, Pollen abnormal |
1863: Decrease, Reproduction |
Jan 21, 2022 |
Jan 21, 2022 |
1 AOP
|
| 2070 |
1754: Increase, porcupine-induced Wnt secretion and Wnt signaling activation |
1755: beta-catenin activation |
Mar 23, 2020 |
Nov 9, 2021 |
1 AOP
|